Jubilant Pharmova Profile
Key Indicators
- Authorised Capital ₹ 143.02 Cr
- Paid Up Capital ₹ 15.93 Cr
- Company Age 46 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 500.00 Cr
- Satisfied Charges ₹ 8,995.57 Cr
- Revenue Growth 343.79%
- Profit Growth -36.46%
- Ebitda 147.53%
- Net Worth 88.37%
- Total Assets 64.44%
About Jubilant Pharmova
Jubilant Pharmova Limited (JPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 21 June 1978 and has a history of 46 years and nine months. Its registered office is in Jyotiba Phule Nagar, Uttar Pradesh, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530019 and on the National Stock Exchange(NSE) under JUBLPHARMA.
The Corporate was formerly known as Vam Organic Chemicals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 143.02 Cr and a paid-up capital of Rs 15.93 Cr.
The company currently has active open charges totaling ₹500.00 Cr. The company has closed loans amounting to ₹8,995.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jubilant Pharmova Limited India are Arvind Chokhany as Cfo, Naresh Kapoor as Company Secretary, and Naresh Kapoor as Company Secretary. Shyam Bhartia, Vivek Mehra, Arun Seth, and Nine other members serve as directors at the Company.
Company Details
- Location
Jyotiba Phule Nagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24116UP1978PLC004624
- Company No.
004624
- Stock Symbol
BSE : 530019 NSE : JUBLPHARMA
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jun 1978
- Date of AGM
30 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Kanpur
Industry
Pharma
What products or services does Jubilant Pharmova Limited offer?
Jubilant Pharmova Limited offers a wide range of products and services, including Organic Compounds, Piperidine, Third Party Manufacturing Consultancy, Contract Manufacturing Services, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Pharmaceutical Services.
Jubilant Pharmova Limited
Explore comprehensive data for Jubilant Pharmova Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Jubilant Pharmova?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyavrat Bhartia  | Managing Director | 23-May-2017 | Current |
| Arjun Bhartia | Managing Director | 23-May-2017 | Current |
| Arvind Chokhany | CFO | 27-Jun-2023 | Current |
| Naresh Kapoor | Company Secretary | 01-Aug-2022 | Current |
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Mehra | Director | 23-May-2017 | Current |
| Sushil Roongta | Director | 23-May-2017 | Current |
| Shirish Belapure | Director | 07-Mar-2023 | Current |
| Arul Ramakrishnan | Whole-Time Director | 01-Jun-2024 | Current |
| Arun Seth | Director | 22-Oct-2018 | Current |
| Shyam Bhartia | Director | 21-Jun-1978 | Current |
Financial Performance of Jubilant Pharmova.
Jubilant Pharmova Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 343.79% increase. The company also saw a substantial fall in profitability, with a 36.46% decrease in profit. The company's net worth Soared by an impressive increase of 88.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jubilant Pharmova?
In 2022, Jubilant Pharmova had a promoter holding of 50.68% and a public holding of 49.33%. The company had 7 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Usha Breco LimitedArun Seth is a mutual person
_PRIVATE_LIMITED.webp)
Pamp Technologies (India) Private LimitedArun Seth is a mutual person
Jubilant Enpro Private LimitedShyam Bhartia, Arjun Bhartia and 2 more are mutual person
Jubilant Bhartia FoundationShyam Bhartia, Arvind Chokhany and 1 more are mutual person
Mahajan Imaging Caring Research LlpHarsh Mahajan is a mutual person
Titagarh Rail Systems LimitedSushil Roongta is a mutual person
Charges (Loans)
Open Charges
₹500.00 Cr
Satisfied Charges
₹8,995.57 Cr
Charges Breakdown by Lending Institutions
- Others : 230.00 Cr
- Axis Bank Limited : 120.00 Cr
- Hdfc Bank Limited : 100.00 Cr
- Yes Bank Limited : 50.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2024 | Hdfc Bank Limited | ₹100.00 Cr | Open |
| 28 Aug 2023 | Others | ₹100.00 Cr | Open |
| 23 Mar 2023 | Yes Bank Limited | ₹50.00 Cr | Open |
| 15 Feb 2023 | Others | ₹60.00 Cr | Open |
| 20 Sep 2022 | Others | ₹70.00 Cr | Open |
How Many Employees Work at Jubilant Pharmova?
Jubilant Pharmova has a workforce of 1055 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jubilant Pharmova, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Pharmova's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Jubilant Pharmova
Recent activity within the organization
- Annual General Meeting
Jubilant Pharmova Limited last Annual general meeting of members was held on 30 Aug 2024 as per latest MCA records.
- Director Appointment
Arul Ramakrishnan was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 01 Jun 2024 & has been associated with this company since 10 months 12 days .
- Director Appointment
Shivpriya Nanda was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 12 days .
- Director Appointment
Harsh Mahajan was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 12 days .
- Balance Sheet
Jubilant Pharmova Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 100.00 Cr with Charge ID 100882140 was registered on 26 Feb 2024.
Recent News, Updates & Announcement
- Jubilant Pharmova Q1 FY-24: Net profit declines by 86% followed by 3% decline in stocks.
The company has reported a year-on-year decline in all major financial metrics barring revenue for the recently ended quarter .
- Jubilant Pharmova announces leadership changes; Priyavrat Bhartia takes over as MD.
Jubilant Pharmova Ltd on Tuesday announced leadership changes and board composition with Priyavrat Bhartia being appointed as Managing Director with incumbent Co-Chairman & Managing Director Hari S Bhartia deciding to step down as as part of its succession planning strategy. Priyavrat Bhartia, son of Chairman Shyam S Bhartia, will take over as Managing Director effective June 1, 2023. He has been a non-executive director since May 2017.
Frequently asked questions
What is the Incorporation or founding date of Jubilant Pharmova Limited?
Jubilant Pharmova Limited was incorporated on 21 Jun 1978.
What is authorized share capital and paid-up capital of Jubilant Pharmova Limited?
The authorized share capital of Jubilant Pharmova Limited is ₹ 143.02 Cr and paid-up capital is ₹ 15.93 Cr.
Who are the current board members & directors of Jubilant Pharmova Limited?
Currently 15 directors are associated with Jubilant Pharmova Limited.
- Shyam Sunder Bhartia
- Vivek Mehra
- Arun Seth
- Sushil Kumar Roongta
- Shirish Gundopant Belapure
- Arjun Shanker Bhartia
- Arvind Chokhany
- Arul Ramakrishnan
- Arvind Chokhany
- Naresh Kapoor
- Naresh Kapoor
- Shivpriya Nanda
- Harsh Mahajan
- Priyavrat Bhartia
- Hari Shanker Bhartia
What is the registered address of Jubilant Pharmova Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Jubilant Pharmova Limited is Bhartiagram Gajraulajyotiba Phoolay Nagar India, U P, Uttar Pradesh, 244223.
What is the corporate identification number (CIN) and company number of Jubilant Pharmova Limited?
The corporate identification number (CIN) of Jubilant Pharmova Limited is L24116UP1978PLC004624 and the company number is 004624 as per Ministry of Corporate Affairs (MCA).
Is Jubilant Pharmova Limited registered with any stock exchange in India?
Yes, Jubilant Pharmova Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): JUBLPHARMA.
What is the official website of Jubilant Pharmova Limited?
The Official website of Jubilant Pharmova Limited is https://www.jubilantpharmova.com
What has been the recent revenue trend for Jubilant Pharmova Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Jubilant Pharmova Limited has risen by 343.79%.
How many employees does Jubilant Pharmova Limited currently have?
As Per 2023 financial reports, 1055 employees are currently employed by Jubilant Pharmova Limited.
What change has been observed in the net worth of Jubilant Pharmova Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Jubilant Pharmova Limited has experienced an upsurge of 88.37%.
What are the total open charges for Jubilant Pharmova Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Jubilant Pharmova Limited amount to ₹ 500.00 Cr.
When was the last Balance Sheet of Jubilant Pharmova Limited filed with the ROC?
The most recent Balance Sheet for Jubilant Pharmova Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Suresh KumarDirector
Surendra SinghDirector
Sudha PillaiDirector
Srinivasan SridharDirector
Ashok MisraDirector
Ajay RelanDirector
Abhay HavaldarDirectorSS
Shardul ShroffDirector
Similar Companies Based on API Manufacturers
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Msn Laboratories Private Limited Rangareddy, Telangana, India
Lupin Limited Mumbai, Maharashtra, India
Ipca Laboratories Limited Mumbai, Maharashtra, India
Divi's Laboratories Limited Rangareddy, Telangana, India
Hetero Labs Limited Rangareddy, Telangana, India
Glenmark Pharmaceuticals Limited Mumbai, Maharashtra, India